An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

PHASE2TerminatedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

November 14, 2019

Study Completion Date

November 14, 2019

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

BG00011

Administered as specified in the treatment arm.

DRUG

Placebo

Administered as specified in the treatment arm.

Trial Locations (90)

1070

Research Site, Brussels

2010

Research Site, Darlinghurst

2042

Research Site, Newtown

2305

Research Site, New Lambton Heights

2900

Research Site, Hellerup

3000

Research Site, Leuven

3004

Research Site, Melbourne

3080

Research Site, Seoul

3084

Research Site, Heidelberg

3939

Research Site, Frankston

4000

Research Site, San Miguel de Tucumán

4012

Research Site, Nundah

4032

Research Site, Chermside

4102

Research Site, Woolloongabba

5530

Research Site, Yvoir

6150

Research Site, Murdoch

8000

Research Site, Aarhus C

10029

Research Site, New York

13620

Research Site, Seongnam-si

15213

Research Site, Pittsburgh

20123

Research Site, Milan

22042

Research Site, Falls Church

28006

Research Site, Madrid

29425

Research Site, Charleston

30322

Research Site, Atlanta

33125

Research Site, Miami

34295

Research Site, Montpellier

34362

Research Site, Haifa

35033

Research Site, Rennes

35294

Research Site, Birmingham

37232

Research Site, Nashville

41013

Research Site, Seville

41110

Research Site, Larissa

44195

Research Site, Cleveland

46014

Research Site, Valencia

47100

Research Site, Forlì

49100

Research Site, Petah Tikva

52242

Research Site, Iowa City

53100

Research Site, Siena

53792

Research Site, Madison

55407

Research Site, Minneapolis

55905

Research Site, Rochester

63017

Research Site, Chesterfield

66160

Research Site, Kansas City

69677

Research Site, Bron

71110

Research Site, Heraklion

75877

Research Site, Paris

77030

Reserach Site, Houston

85006

Research Site, Phoenix

85013

Research Site, Phoenix

90048

Research Site, Los Angeles

91120

Research Site, Jerusalem

93009

Research Site, Bobigny

95123

Research Site, Catania

98195

Research Site, Seattle

98405

Research Site, Tacoma

150003

Research Site, Yaroslavl

197022

Research Site, Saint Petersburg

420103

Research Site, Kazan'

620039

Research Site, Yekaterinburg

3465586

Research Site, Talca

4428164

Research Site, Kfar Saba

06510-3221

Research Site, New Haven

02114

Research Site, Boston

02115

Research Site, Boston

03756

Research Site, Lebanon

02903

Research Site, Providence

B7600FZ

Research Site, Mar del Plata

775 20

Research Site, Olomouc

305 99

Research Site, Plzen Bory

140 59

Research Site, Prague

180 01

Research Site, Prague

00168

Research Site, Roma

1091 AC

Research Site, Amsterdam

3435 CM

Research Site, Nieuwegein

3015 CE

Research Site, Rotterdam

80-952

Research Site, Gdansk

01-138

Research Site, Warsaw

05505

Research Site, Seoul

08907

Research Site, L'Hospitalet de Llobregat

08006

Research Site, Barcelona

08025

Research Site, Barcelona

CB2 0AY

Research Site, Cambridge

EX2 5DW

Research Site, Exeter

SW3 6NP

Research Site, London

W12 0HS

Research Site, London

EH4 2XU

Research Site, Edinburgh

L9 7AL

Research Site, Liverpool

NE1 4LP

Research Site, Newcastle

LS9 7TF

Research Site, Leeds

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY